| 8.00 |
Registration |
| 9.00 |
Welcome and Introduction
A. Piaggesi |
| 9.15 |
Opening Lecture
Chairman: A. Piaggesi
L'epidemiologia del piede diabetico ischemico
E. Faglia |
| 9.45-11.00 |
| Pathogenesis |
| Chairman: M. Edmonds |
| 09.45 |
Insulin-resistance, inflammation and PAD
A. Ceriello |
| 10.05 |
Peculiarity of the diabetic macroangiopathy
M. Edmonds |
| 10.25 |
New markers for an old disease
R. Miccoli |
| 10.45 |
Discussion |
|
| 11.00 |
For Debate
Is preliminary diagnostic assessment always necessary
before intervention?
Chairman: E. Minar
YES: I. Bargellini NO: J. Clerissi |
| 12.00 |
Sala Perla
Symposium
Are latest results of coronary Drug Eluting Stent (DES)
in diabetic reliable?
Chairman: A. S. Petronio
Discussant:
- Coronary artery disease (CAD) in diabetics: epidemiology, outcome, diagnosis
A. Piaggesi
-Which Coronary Stent in diabetics: the evidence of numebers
F. Airoldi
- The dark side of coronary DES trials: which kind of diabetics have been enrolled?
F. Fabbiocchi
- Final Remarks
A. S. Petronio
with the support of Abbott Vascular
|
| 13.00 |
Lunch - Exhibition viewing |
| 14.00 |
Lecture
Chairman: J. Apelqvist
The ischemic diabetic foot in Europe, insights from
the Eurodiale Study
N. Schaper
|
| 14.30-15.30 |
| Co-morbidity |
| Chairmen: L.Ricci, G.Wolf |
| 14.30 |
The heart-foot syndrome
F. Liistro |
| 14.50 |
The head-foot syndrome
M. De Carlo |
| 15.10 |
The kidney-foot syndrome
G. Wolf |
|
| 15.30-16.30 |
| Medical therapy for the ulcerated ischemic foot |
| Chairman: J. Apelqvist |
| 15.30 |
The anti infective therapy in the ischemic foot
F. Menichetti
|
| 15.50 |
The role of metabolic control
G. Ghirlanda |
| 16.10 |
New indications for old drugs: the adjuvant therapies revisited
L. Uccioli |
|
| 16.30 |
For Debate
Antiplatelets vs anticoagulants in the management
of the diabetic patients with PAD
Chairman: E. Faglia
Antiplatelets: J. Dorffler-Melly
Anticoagulants: R. De Caterina |
| 17.30-18.30 |
Sala Perla
Symposium
Premises and Promises of Drug Eluting Balloons (DEB)
in peripheral Interventions
Chairman: G. Ansel/ Co- Chairman: B. Scheller
Discussant:
- Drug eluting balloons (DEB)from inception to clinical use
B. Scheller
- Long lesion and occlusion in BTK
A. Schimdt
- Diabetic hand
R. Ferraresi
- Hemodyalisi Shunts
P. Pattynama
- Femoral an Popliteal
T. Zeller
with the support of Invatec
|
|
April 23, 2010
Salone delle Feste
ISCHEMIC FOOT PROGRAM
|
| 9.00 |
Lecture
Chairman: S. van Baal
A surgery dedicated to the diabetic foot
D. Armstrong |
| 9.30-10.45 |
| Surgical therapy |
| Chairman: A. Piaggesi , S. Van Baal |
| 9.30 |
The perioperative management of diabetic foot patients
B. Kuppers |
| 9.50 |
Surgical drainage of the infected foot
J. Aragon Sanchez |
| 10.10 |
Surgical reconstructive techniques
A. Piaggesi |
| 10.30 |
Discussion |
|
| 10.45 |
Clinical Cases
Chairmen: A. Piaggesi, E. Faglia
Panelists: G. Clerici, L. Dalla Paola, F. Romagnoli |
| 11.30 |
Lecture
Chairman: L. Uccioli
Innovative approach to the treatment of severe diabetic foot infection: a new surgical protocol.
C. Caravaggi |
| 12.00 |
Sala Perla
Symposium
The future of V.A.C. ® Therapy
Chairman: A. Piaggesi
Discussant:
- VAC Therapy and the Diabetic Foot Scenario
A. Piaggesi
- Use of VAC as adjuvant therapy in selected clinical cases
L. Dalla Paola
- Making sense of VAC Therapy. Challanges for the future
S. Vig
with the support of KCI
|
| 13.00 |
Lunch - Exibition Viewing |
| 14.30 |
Lecture
Chairman: G. Ghirlanda
The stratification of the risk in the multi-complicated patient
J. Apelqvist |
| 15.00 |
New technologies for the management
of the diabetic ischemic leg
Chairman A. Piaggesi
Frequency- modulated electromagnetic stimulation (FREMS) in the management of the ischemic leg
R. Da Ros
Nanotecnologies in the treatment for the prevention and rehabilitation of the ischemic leg
E. Banchellini
|
| 16.00 |
For Debate
Does revascularization always precede surgery?
Chairman: D. Armstrong
Yes: S. Van Baal No:G. Clerici |
